Sign in

Cyrille Pichot

Research Analyst at Altimeo

Cyrille Pichot is an Analyst at Altimeo, specializing in European equity research with a focus on the financial, real estate, and infrastructure sectors. He actively covers companies such as Unibail-Rodamco-Westfield, Mercialys, and Klepierre, providing detailed analysis and actionable investment strategies. Since joining Altimeo in 2018, Pichot has demonstrated strong performance with above-benchmark annualized returns on recommended equities and maintains a success rate above 65% on recognized platforms. Prior to Altimeo, he held analytical roles at emerging market investment firms and is recognized for his rigorous approach and professional credentials, including European financial analyst certifications.

Cyrille Pichot's questions to Global Cord Blood (CORBF) leadership

Question · Q4 2021

Cyrille Pichot from Altimeo posed questions regarding the company's acquisition strategy outside of China, its plans for the Qilu stake, and its potential interest in a secondary Hong Kong listing due to new regulations and U.S. delisting risks.

Answer

CFO Bing Chen confirmed the company is actively exploring acquisition opportunities both within and outside of China to expand its service portfolio and mitigate geographical and regulatory risks. He highlighted uncertainties from the new Biosecurity Law and a pause on new cord blood banking licenses as drivers for this strategy. Regarding a Hong Kong listing, Mr. Chen noted he was monitoring the U.S. PCAOB situation but was not aware of the specific listing rule changes mentioned.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts